Angle PLC Announces New Commercial Agreement with AstraZeneca
Accesswire
*ANGLE signs agreement to tailor existing Parsortix-based DNA damage response assay for use in pharmaceutical..
*ANGLE signs agreement to tailor existing Parsortix-based DNA damage response assay for use in pharmaceutical..
The Israel-Hamas war reached its gruesome six-month mark Saturday and is considered one of the most destructive, deadly, and..
*PARSORTIX SYSTEM AND ASSAYS BEING SHOWCASED AT A LEADING EUROPEAN BREAST CANCER CONFERENCE*
*ANGLE presenting two..